EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Copeptin as a novel marker for predicting the prognosis of fatty liver disease and its complications in obesity

Abeer Cheaid Yousif Al-Fatlawi, Ameer Nazim Kamel, Bashir Ghafel Hwan, Alwan Karem Alwan, Muhammad hamed Jasim

Al-Ameed Journal for Medical Research and Health Sciences · 16.03.2024 · 1 (2)

DOI: 10.61631/3005-3188.1009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Al-Ameed Journal for Medical Research and Health Sciences, online erschienen am 16.03.2024. Verfasst von Abeer Cheaid Yousif Al-Fatlawi und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Copeptin is an independent, persistent plasma marker for vasopressin (VP) linked to all aspects of the metabolic syndrome and overweight. The study aimed to evaluate copeptin levels as a surrogate marker for predicting liver disorders in obese patients. Methods: cross sectional study include 20 obese males with mean of age (42.50± 3.17) years and 20 obese females with mean of ages (44.55±2.82) years, the plasma copeptin level was masured and related with fatty liver disease according to a validated liver enzyme, lipid profile, BMI and abdominal ultrasound.

Results

Highly significant increase liver enzyme, lipid profile and BMI in both males and females obese fatty liver patients, significant elevated Copeptin concentration in both gender (13.84±0.27), (13.88±0.40) and highly significant positive correlated with ferritin, BMI and TC, (r=0.651, 0.496, 0.491 and 0.457), while showed Copeptin significant negative correlated with HDL (-0.508, -0.490). Conclusions: obese individuals with the fatty liver disease showed associated with highly increased plasma copeptin, also this marker considers a useful tool for the diagnostic pathway to risk factors of metabolic disease such as diabetes mellitus although this hypothesis needs further studies to be confirmed.

Zitieren

APA

Al-Fatlawi, A. C. Y., Kamel, A. N., Hwan, B. G., Alwan, A. K., & Jasim, M. H. (2024). Evaluation of Copeptin as a novel marker for predicting the prognosis of fatty liver disease and its complications in obesity. Al-Ameed Journal for Medical Research and Health Sciences, 1(2). https://doi.org/10.61631/3005-3188.1009

Vancouver

Al-Fatlawi ACY, Kamel AN, Hwan BG, Alwan AK, Jasim MH. Evaluation of Copeptin as a novel marker for predicting the prognosis of fatty liver disease and its complications in obesity. Al-Ameed Journal for Medical Research and Health Sciences. 2024;1(2). doi:10.61631/3005-3188.1009

BibTeX
@article{AlFatlawi2024,
  author = {Al-Fatlawi, Abeer Cheaid Yousif and Kamel, Ameer Nazim and Hwan, Bashir Ghafel and Alwan, Alwan Karem and Jasim, Muhammad hamed},
  title = {Evaluation of Copeptin as a novel marker for predicting the prognosis of fatty liver disease and its complications in obesity},
  journal = {Al-Ameed Journal for Medical Research and Health Sciences},
  year = {2024},
  volume = {1},
  number = {2},
  doi = {10.61631/3005-3188.1009}
}
Kostenlos starten →